香雪XPH品牌怎么样 申请店铺

我要投票 香雪XPH在医疗器械行业中的票数:186 更新时间:2025-04-27
香雪XPH是哪个国家的品牌?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!通过在本页面挂载香雪XPH品牌的产品链接和联系方式,可以提高香雪XPH产品曝光!跨境电商爆单神器,目前只要100元/年哦~

香雪XPH怎么样

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://brand.waitui.com/5a03ebbad.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美团:“因使用双开或京东软件,被永久停止接单”系恶意P图造谣

4月27日,美团发布声明称,在澄清“去其他平台跑单会被美团永久封号”的谣言后,社交平台上依旧出现了骑手App显示“永久停止接单原因为:存在使用双开或京东软件的行为”的谣言图片。经核实,该图片源自平台封禁违规抢单外挂的正常提示页,但ip地址在广东的个别网民,对图片进行恶意P图后,极少数网民在微信群内进行传播。目前公司已针对谣言传播情况进行证据固定,将通过法律手段维护自身权益。对于恶意发布上述不实图片,持续散播谣言的虚假摆拍账号、幕后推手,公司也会加大固证和打击力度。(界面新闻)

2小时前

万事网联推出支付标记化服务

36氪获悉,4月25日,万事网联正式推出支付标记化服务。支付标记化服务,即应用支付标记化技术(Tokenization),替代银行卡卡号、卡片验证码、支付机构支付账户等敏感信息,并通过设置支付标记的交易次数、交易金额、有效期和支付渠道等约束规则,从源头控制信息泄露和欺诈交易风险。通过这项服务,交易全程无须出现银行卡卡号、有效期等关键信息,持卡人可以实现在数字钱包或超级应用上的无卡支付,还可以绑定智能手机、可穿戴设备在线下使用,在保障安全的同时提升支付便利性。

2小时前

许晓征任深圳金融监管局副局长

36氪获悉,4月27日,国家金融监督管理总局深圳监管局网站“局领导”栏目更新显示,许晓征任国家金融监督管理总局深圳监管局党委委员、副局长。

2小时前

纳芯微汽车芯片累计出货6.68亿颗

36氪获悉,近日,纳芯微亮相2025年上海国际车展5.2馆“中国芯”展区。据介绍,截止2024年,纳芯微汽车芯片累计出货量达6.68亿颗,仅在新能源汽车三电系统领域,纳芯微已为近400家零部件供应商建立深度合作,为主驱逆变器、车载充电机(OBC)、电池管理系统(BMS)等领域提供完整的芯片解决方案。

2小时前

苏州恒道餐饮管理有限公司完成1200万元A轮融资

36氪获悉,近日,苏州恒道餐饮管理有限公司旗下品牌“福来魏”完成1200万元A轮融资,本轮由上海潮信实业投资有限公司投资。此次融资将主要用于供应链体系升级、数字化系统建设及全国市场拓展。福来魏创立于2017年,以陕西凉皮、肉夹馍、油泼面三大爆款为核心,延伸出30余款高复购率产品矩阵。

2小时前

本页详细列出关于香雪XPH的品牌信息,含品牌所属公司介绍,香雪XPH所处行业的品牌地位及优势。
咨询